Heart drug developer Kardigan is targeting a $1.4 billion valuation in its U.S. IPO
Colleen Cabi
·
2026-06-11
·
via Quartz
The Princeton, N.J., biotech plans to raise up to $373.3 million by selling 23.3 million shares priced betwee…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。